Everything below concerns regulatory schedule. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-12-16. Numbers and descriptions here follow the published literature rather than marketing material.
Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.
No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.
Lyophilised melanotan-2 is comparatively robust when kept dry, cold and dark, and a desiccated powder stored at minus twenty degrees Celsius or below is generally expected to retain its chemical integrity for extended periods. In solution the peptide is far less stable, with degradation proceeding through oxidation of tryptophan and histidine residues, hydrolysis adjacent to the lactam bridge, and aggregation at higher concentrations. Repeated freeze-thaw cycling accelerates loss of the parent peak. Working aliquots are therefore prepared once, held cold, and used without letting the stock return to ambient temperature.
Quality assessment of research-grade peptide rests mainly on reversed-phase high-performance liquid chromatography for purity and on mass spectrometry for identity confirmation. A single main peak above a stated threshold, commonly ninety-eight percent by peak area, is the usual release criterion applied by suppliers. Independent analyses commissioned by laboratories and consumer organisations have repeatedly reported discrepancies between label claims and measured content, including truncated sequences, residual trifluoroacetate, and lower-than-declared peptide mass. Those findings do not establish that every supplier is unreliable, but they indicate that purity figures printed on a vial are claims requiring verification rather than settled facts.
Regulatory treatment varies by jurisdiction and has changed over time. In several countries the peptide is handled as an unapproved prescription medicine, and import or sale for human use is restricted, while elsewhere it falls under poisons or controlled-substance schedules. Enforcement activity against online vendors has been reported in Australia, New Zealand, the United Kingdom and the United States. Scholarly writing discusses melanotan-2 chiefly as an experimental tool and as a case study in unregulated peptide supply, and its precise legal position in any given country should be checked against current national schedules.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H69N15O9 | Free base; salt forms add to total mass |
| Molecular mass | About 1024 daltons | Calculated for the free base |
| Structural class | Cyclic heptapeptide | Contains D-phenylalanine and norleucine |
| Parent hormone | Alpha-melanocyte-stimulating hormone | Endogenous tridecapeptide of 13 residues |
| Receptor profile | Non-selective melanocortin agonist | Interacts with MC1R, MC3R, MC4R and MC5R |
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
Identity testing for a synthetic peptide relies on several complementary methods. Reversed-phase high-performance liquid chromatography separates the target from related impurities and reports purity as a percentage of total peak area. Mass spectrometry confirms molecular mass and can reveal deletions or truncations. Amino acid analysis and peptide mapping provide sequence-level confirmation, while counter-ion content and residual solvents are measured separately. A purity figure alone does not establish identity, so a complete dataset combines chromatographic and spectrometric evidence.
Lyophilized peptide powder is generally stored frozen, protected from light and moisture. Tryptophan residues are susceptible to oxidation, and the lactam bridge can hydrolyze under strongly acidic or basic conditions. Solutions prepared for laboratory work degrade faster than dry powder, and repeated freeze-thaw cycles accelerate loss. Common practice is to aliquot solutions before freezing and to avoid alkaline buffers. Reported stability windows vary with concentration, buffer, and temperature, so exact shelf lives are method-specific rather than universal.
== Interactions == Cilostazol is metabolized by CYP3A4 and CYP2C19, two isoenzymes of the cytochrome P450 system. Drugs that inhibit CYP3A4, such as itraconazole, erythromycin, ketoconazole, and diltiazem, are known to interact with cilostazol. The proton pump inhibitor omeprazole, an inhibitor of CYP2C19, increases exposure to the active metabolite of cilostazol. A single report has been made of grapefruit juice possibly increasing the effects of cilostazol; some drug information sources list this as a possible interaction. The FDA-approved labeling of cilostazol notes that grapefruit juice (which is a CYP3A4 inhibitor) increases the drug's maximum concentration by around 50%.
His Imperial and Royal Apostolic Majesty, Francis Joseph I, by the Grace of God Emperor of Austria, King of Germany, King of Hungary, Bohemia, Lombardy–Venetia, Dalmatia, Croatia, Slavonia, Galicia, Lodomeria, Illyria, Serbia, Cumania, Bulgaria, Italy, Rama, Romania, King of Jerusalem, etc. etc.; Archduke of Austria; Grand Duke of Tuscany; Duke of Lorraine, Salzburg, Styria, Carinthia, Carniola and Bukovina; Grand Prince of Transylvania, Margrave of Moravia; Duke of Upper and Lower Silesia, of Modena, Parma, Piacenza and Guastalla, of Auschwitz and Zator, of Teschen, Friaul, Ragusa and Zara and Teck; Princely Count of Habsburg and Tyrol, of Kyburg, Gorizia and Gradisca; Prince of Trento and Brixen; Margrave of Upper and Lower Lusatia, Istria; Count of Hohenems, Feldkirch, Bregenz, Sonnenberg, etc. etc.; Lord of Trieste, of Cattaro and on the Windic March; Grand Voivode of the Voivodeship of Serbia, etc. etc.
Hemoglobin is an oxygen carrier that occurs in red blood cells and contributes their color, transporting oxygen in the arteries from the lungs to the muscles where it is transferred to myoglobin, which stores it until it is needed for the metabolic oxidation of glucose, generating energy. Here the hemoglobin binds to carbon dioxide, produced when glucose is oxidized, which is transported through the veins by hemoglobin (predominantly as bicarbonate anions) back to the lungs where it is exhaled. In hemoglobin, the iron is in one of four heme groups and has six possible coordination sites; four are occupied by nitrogen atoms in a porphyrin ring, the fifth by an imidazole nitrogen in a histidine residue of one of the protein chains attached to the heme group, and the sixth is reserved for the oxygen molecule it can reversibly bind to. When hemoglobin is not attached to oxygen (and is then called deoxyhemoglobin), the Fe2+ ion at the center of the heme group (in the hydrophobic protein interior) is in a high-spin configuration. It is thus too large to fit inside the porphyrin ring, which bends instead into a dome with the Fe2+ ion about 55 picometers above it. In this configuration, the sixth coordination site reserved for the oxygen is blocked by another histidine residue. When deoxyhemoglobin picks up an oxygen molecule, this histidine residue moves away and returns once the oxygen is securely attached to form a hydrogen bond with it.
Sources: en.wikipedia.org
=== Transportation === Steel belts may be used to move the finished product or raw material or in parcel sorting systems, transporting of bottles, bulk loads, bricks, machinery parts and the like. Straight tracking, high abrasion resistance, and dynamic fatigue strength are crucial when transporting bulky material or unit load. Extremely high operating speeds cause a high number of load cycles and create severe operating conditions. Steel belts can be made to suit these extreme requirements.
Decay modes in parentheses are given for observationally stable nuclides (these and these); they are then those allowed to occur by energy (in the next column), but spontaneous fission (and cluster decay, which is never shown in the tables) are neglected as they should never be observed for these nuclides. Those with multiple significant decay modes have the probability of each decay mode in percent given, in small figures, in parentheses; those less than 0.05% are rounded to zero and omitted, and 100 (>99.5% of observed decays) is not used but replaced by bold unless the only other decays are SF or double beta, assumed to be minority decays if not listed first. If more than one of α, β−, β+/ε, IT is given without numbers or bold, one can assume no experimental data is available. Note that, by widely used convention, β+ (technically positron emission) includes ε, and conversely, if positron emission is energetically possible; the two are never separated on this page.
Calcium and bone disorders: Endocrinologists also treat conditions that affect calcium levels in the blood, such as hyperparathyroidism (high amounts of parathyroid hormone) and osteoporosis (weak bones). Sexual and reproductive disorders: Endocrinologists can also help diagnose and treat hormonal problems that affect sexual development and function, such as polycystic ovary syndrome (PCOS) and erectile dysfunction. Endocrine cancers: These are cancers that develop in the endocrine glands. Endocrinologists can help diagnose and treat these cancers.
Sources: en.wikipedia.org
=== Innovations === The initial stages of the Industrial Revolution had much to do with larger military forces—it became easy to mass-produce weapons and thus to equip larger forces. Britain was the largest single manufacturer of armaments in this period. It supplied most of the weapons used by the coalition powers throughout the conflicts. France produced the second-largest total of armaments, equipping its own huge forces as well as those of the Confederation of the Rhine and other allies. Napoleon showed innovative tendencies in his use of mobility to offset numerical disadvantages, as demonstrated in the rout of the Austro–Russian forces in 1805 in the Battle of Austerlitz. The French Army redefined the role of artillery, forming independent, mobile units, as opposed to the previous tradition of attaching artillery pieces in support of troops. The semaphore system had allowed the French War-Minister, Carnot, to communicate with French forces on the frontiers throughout the 1790s. The French continued to use this system throughout the Napoleonic wars. Aerial surveillance was used for the first time when the French used a hot-air balloon to survey coalition positions before the Battle of Fleurus, on 26 June 1794.
2 GSH + R-S-S-R → GSSG + 2 RSH The GSH:GSSG ratio is therefore an important bioindicator of cellular health, with a higher ratio signifying less oxidative stress in the organism. A lower ratio may even be indicative of neurodegenerative diseases, such as Parkinson's disease (PD) and Alzheimer's disease.
==== MeSH E05.196.712 – photometry ==== MeSH E05.196.712.224 – densitometry MeSH E05.196.712.224.187 – absorptiometry, photon MeSH E05.196.712.224.375 – densitometry, x-ray MeSH E05.196.712.516 – luminescent measurements MeSH E05.196.712.516.200 – chemiluminescent measurements MeSH E05.196.712.516.600 – fluorometry MeSH E05.196.712.516.600.240 – cytophotometry MeSH E05.196.712.516.600.240.350 – flow cytometry MeSH E05.196.712.516.600.240.400 – image cytometry MeSH E05.196.712.516.600.240.400.500 – laser scanning cytometry MeSH E05.196.712.516.600.390 – fluorescence polarization MeSH E05.196.712.516.600.390.350 – fluorescence polarization immunoassay MeSH E05.196.712.516.600.393 – fluorescence recovery after photobleaching MeSH E05.196.712.516.600.410 – fluorophotometry MeSH E05.196.712.516.600.676 – spectrometry, fluorescence MeSH E05.196.712.516.600.676.500 – fluorescence resonance energy transfer MeSH E05.196.712.650 – nephelometry and turbidimetry MeSH E05.196.712.726 – spectrophotometry MeSH E05.196.712.726.300 – microspectrophotometry MeSH E05.196.712.726.551 – spectrophotometry, atomic MeSH E05.196.712.726.676 – spectrophotometry, infrared MeSH E05.196.712.726.676.700 – spectroscopy, fourier transform infrared MeSH E05.196.712.726.802 – spectrophotometry, ultraviolet
Sources: en.wikipedia.org
No regulatory agency has authorised melanotan-2 as a medicine for any indication. It circulates mainly as a research chemical or through unregulated channels. As a result, identity, purity and content are not independently guaranteed.
Melanotan-1, also called afamelanotide, is a linear analogue with greater selectivity for MC1R and has received approval in some jurisdictions for a specific photosensitivity disorder. Melanotan-2 is cyclic, less selective, and reaches central receptors more readily. The two are often confused in online discussion despite different pharmacology and regulatory status.
Alpha-MSH is an endogenous tridecapeptide derived from pro-opiomelanocortin. Melanotan-2 reproduces its core receptor-binding sequence inside a shortened, stabilised ring. The result is a molecule with a longer effective half-life and higher potency than the parent hormone.
Solutions are best kept cold, protected from light, and buffered to a pH that limits hydrolysis. Dividing a stock into single-use aliquots avoids repeated freeze-thaw cycles, which measurably reduce the intact parent peak over time.